---
figid: PMC9701058__13062_2022_348_Fig12_HTML
pmcid: PMC9701058
image_filename: 13062_2022_348_Fig12_HTML.jpg
figure_link: /pmc/articles/PMC9701058/figure/Fig12/
number: Fig. 12
figure_title: ''
caption: C646 treatment inhibited MC38CXCL1+/+ colon cancer tumor progression. a–c
  Photographs of the tumor after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+).
  d–f Mean tumor volume after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+).
  g–i Mean tumor weight after treatment with C646 (MC38 WT, MC38CXCL1−/−, MC38CXCL1+/+).
  ns no significant, **P < 0.01, ***P < 0.001
article_title: CXCL1 promotes colon cancer progression through activation of NF-κB/P300
  signaling pathway.
citation: Changhua Zhuo, et al. Biol Direct. 2022;17:34.
year: '2022'

doi: 10.1186/s13062-022-00348-4
journal_title: Biology Direct
journal_nlm_ta: Biol Direct
publisher_name: BioMed Central

keywords:
- CXCL1
- Colon cancer
- NF-κB
- P300
- C646

---
